Results 241 to 250 of about 14,305,857 (307)

“Molecular damage and induction of proinflammatory cytokines in human endothelial cells exsposed to Shiga toxin 1, Shiga toxin 2, and alpha-sarcin”

, 2007
ALFIERI RR, CARNICELLI D, BRIGOTTI M, SESTILI P, VARA AG, RAVANELLI E, IMPACT FACTOR, MARTINELLI, CHIARA, PETRONINI PG   +8 more
core   +1 more source

Reporting of morbidity data in general surgery: a one-year cross-sectional analysis of the six journals with the highest impact factor. [PDF]

Int J Surg
Gorini L, De La Plaza Llamas R, Díaz Candelas DA, Díaz Candelas DA, Arellano González R, Sun W, Ramiro Pérez C, León Díaz S, Gemio Del Rey IA.   +8 more
europepmc   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Impact Factor for Journals Specializing in Dental Anesthesiology. [PDF]

Anesth Prog
Sanuki T, Tsukimoto S, Kuroda H, Kido K.
europepmc   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Editorial diversity correlates with journal impact factor and author diversity in cardiothoracic surgery. [PDF]

World J Surg
Martins RS, Umar Z, Amir MA, Jogezai ZH, Ahmed W, Barolia M, Razi SS, Poulikidis K, Latif MJ, Martin LW, Molena D, Bhora FY.   +11 more
europepmc   +1 more source

JSM Impact Factor

The Journal of Sexual Medicine, 2008
openaire   +2 more sources

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

Association of Use of GRADE, Protocol Registration, and Journal Impact Factor With Reporting and Methodological Quality of Systematic Reviews Published in Rehabilitation Journals: A Meta-Epidemiological Study. [PDF]

Cureus
Tsuge T, Yamamoto N, Tomita Y, Hagiyama A, Shiratsuchi D, Okamura M, Kaneko T, Suzuki K, Nakashima Y, Taito S, Yorifuji T.   +10 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source